Journal of Cell Science and Apoptosis
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Case Report   
  • J Cell Sci Apo 1: 105,

Adequate Selection of Oropharynx Carcinoma Treatment in the Elderly

Losada Vila Beatriz*
Hospital University of Fuenlabrada, , Calle Camino del Molino, 2, 28942 Fuenlabrada, Madrid, Spain
*Corresponding Author : Losada Vila Beatriz, Hospital University of Fuenlabrada, Calle Camino Del Molino, 2, 28942 Fuenlabrada, Madrid, Spain, Tel: 677098761, Email: beatriz.losada@salud.madrid.org

Received Date: Apr 10, 2017 / Accepted Date: Apr 16, 2017 / Published Date: Apr 26, 2017

Abstract

Forty seven percent of patients diagnosed in the US between 1973-2008 were ≥ 65 years old and predicted to be >60% by 2030. However, clinical trials do not usually include patients >70 years, so we do not have experience in this increasing field. We present the case of a 79-year-old patient in whom the treatment decision should be well discussed according to comorbidity, treatment toxicity and survival rates.

Keywords: Cetuximab; Elderly; Geriatric assessment scales; Comorbidities; Fragility

Citation: Beatriz LV (2017) Adequate Selection of Oropharynx Carcinoma Treatment in the Elderly. J Cell Sci Apo 1: 105.

Copyright: ©2017 Beatriz LV. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top